Market Value625,043,000
Total Holdings59
File Date2022-05-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
KRTX / Karuna Therapeutics, Inc.
ESTA / Establishment Labs Holdings Inc.
CNTX / Context Therapeutics Inc.
BLU / Bellus Health Inc
VINC / Vincerx Pharma, Inc.
NTLA / Intellia Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
ATHX / Athersys, Inc. Put
CBAY / CymaBay Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
RCOR.WS / Renovacor, Inc. Warrants, enti Warrants, entitling the holder thereof to purchase one-half (1/2) of a share of common stock at a price of $11.50 per whole share
CHAQ / Chardan Healthcare Acquisition 2 Corp
US10806XAD49 / BRIDGEBIO PHARMA INC
SEER / Seer, Inc. Call
PRCT / PROCEPT BioRobotics Corporation
29408N106 / ENVIRONMENTAL IMPACT ACQUISITION CORP
RFL / Rafael Holdings, Inc. Put
KYG5960S1241 / Medicus Sciences Acquisition Corp.
US63009RAD17 / NanoString Technologies Inc
US761299AB20 / Retrophin Inc Bond
ARYD / ARYA Sciences Acquisition Corp IV
LIAN / LianBio - Depositary Receipt (Common Stock)
US10806XAB82 / Bridgebio Pharma, Inc.
/ Nautilus Biotechnology Inc
BEAM / Beam Therapeutics Inc. Call
PTGX / Protagonist Therapeutics, Inc.
PTGX / Protagonist Therapeutics, Inc. Put
ALDX / Aldeyra Therapeutics, Inc.
NSTG / NanoString Technologies, Inc.
AUPH / Aurinia Pharmaceuticals Inc. Call
KDNY / Chinook Therapeutics Inc
CELU / Celularity Inc. Put
LSAQ / LifeSci Acquisition II Corp
MSAC / Medicus Sciences Acquisition Corp - Class A
PMVP / PMV Pharmaceuticals, Inc. Call
IOVA / Iovance Biotherapeutics, Inc.
INO / Inovio Pharmaceuticals, Inc. Call
ARKG / ARK ETF Trust - ARK Genomic Revolution ETF Call
CVAC / CureVac N.V. Call
CRIS / Curis, Inc.
CRIS / Curis, Inc. Call
HYPR / Hyperfine, Inc.
HSAQ / Health Sciences Acquisitions Corp 2
RCKT / Rocket Pharmaceuticals, Inc.
CYCC / Cyclacel Pharmaceuticals, Inc.
CALA / Calithera Biosciences, Inc.
HZNP / Horizon Therapeutics Plc
ARNA / Arena Pharmaceuticals Inc
ARYE / ARYA Sciences Acquisition Corp V - Class A
AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
KURA / Kura Oncology, Inc.
VRDN / Viridian Therapeutics, Inc.
GBT / Global Blood Therapeutics Inc.
MRTX / Mirati Therapeutics, Inc.
NVAX / Novavax, Inc. Put
IMTXW / Immatics N.V. - Equity Warrant
MDGL / Madrigal Pharmaceuticals, Inc.
BPMC / Blueprint Medicines Corporation
CRSP / CRISPR Therapeutics AG Call
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
MRNA / Moderna, Inc. Put
RPTX / Repare Therapeutics Inc.
SPY / SPDR S&P 500 ETF Put
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
SAVA / Cassava Sciences, Inc. Put
TVTX / Travere Therapeutics, Inc.
RLAY / Relay Therapeutics, Inc. Call
CYTK / Cytokinetics, Incorporated
LNTH / Lantheus Holdings, Inc.
LNTH / Lantheus Holdings, Inc. Put
ACRS / Aclaris Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc.
SWTX / SpringWorks Therapeutics, Inc. Put
CLDX / Celldex Therapeutics, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
NARI / Inari Medical, Inc.
MORF / Morphic Holding, Inc.
BBIO / BridgeBio Pharma, Inc.
XENE / Xenon Pharmaceuticals Inc.